Ozanimod, a Selective Selective Sphingosine-1-Phosphatase Receptor Modulator, for Moderate-Severe Ulcerative Colitis: Re-Thinking the Top-Down Treatment Algorithm for UC

Evidence-Based GI: An ACG Publication and Podcast - A podcast by American College of Gastroenterology - Wednesdays

Oriana Damas, MD and Editor-in-Chief Philip Schoenfeld, MD, MSEd, MScEpi discuss “Ozanimod for Induction and Maintenance of Ulcerative Colitis,” by Sandborn WJ, Feagan BG, D’Haens G, et al. N Engl J Med [2021; 385: 1280-91].